The document discusses the pharmaceutical industry in India and analyzes 5 major competitors: Sun Pharmaceuticals, Cipla, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, and Mankind Pharma. It provides details on the companies' products and services, financial resources, business models, market shares, and marketing strategies. It also examines the strengths like in-house R&D and weaknesses of the competitors. The industry is dominated by Sun Pharma, which has the largest market share, followed by Cipla and Dr. Reddy's Laboratories.

1. STRATEGIC MANAGEMENT
GROUP PRESENTATION- MBA 2 E
GROUP NO. 5
OUR MEMBERS-
Vinita Kumari
Visist Tiwari
Vivek Gupta
Walia Fatima
Wasi Arshad
Yash Gupta
Yashi Kesarwani
Yashi Saini
Yogesh Chandra Joshi
Saumya Agarwal

2. “PHARMACEUTICAL INDUSTRY”
COMPETITOR ANALYSIS TABLE.

3. TABLE OF CONTENT:
ABOUT PHARMACEUTICAL INDUSTRY
5 SELECTED COMPETITOR
PRODUCTS & SERVICES OFFER BY THEM
FINANCIAL RESOURCES OF COMPETITORS
BUSINESS MODEL
MARKET SHARES OF COMPETITORS
MARKETING STRATEGY OF COMPETITORS
STRENGTH OF COMPETITORS
WEEKNESS OF COMPETITORS

4. ABOUT PHARMACEUTICAL INDUSTRY
IN INDIA
India is the largest provider of generic drugs globally and is known for its affordable vaccines and
generic medications. The Indian Pharmaceutical industry is currently ranked third in
pharmaceutical production by volume after evolving over time into a thriving industry growing
at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter medications, bulk
drugs, vaccines, contract research & manufacturing, biosimilars, and biologics are some of the
major segments of the Indian pharma industry. India has the most number of pharmaceutical
manufacturing facilities that are in compliance with the US Food and Drug Administration
(USFDA) and has 500 API producers that make for around 8% of the worldwide API market.
https://www.ibef.org/industry/pharmaceutical-india

5. 5 SELECTED COMPETITOR
1. SUN PHARMACETICAL LTD.
2. CIPLA LTD.
3. DR. REDDY’S LABORATORIES LTD.
4. TORRENT PHARMACEUTICALS LTD.
5.MANKIND PHARMA

6. COMPAN
Y
PRICERS. MCAPCR. P/B P/E EPSRS. ROE% ROCE% P/S EV/EBITDA
Sun Pharma
Inds.
1,259.45 3,02,184.24 12.57 411.03 3.06 7.00 7.28 14.52 50.64
Cipla 1,246.30 1,00,620.08 3.89 34.01 36.65 10.49 14.71 6.37 20.25
Dr. Reddy''s
Lab
5,797.90 96,714.42 4.26 25.26 229.54 13.57 18.91 5.70 15.29
Mankind
Pharma
1,982.50 79,416.66 9.16 63.62 31.16 17.43 21.20 9.77 42.64
Torrent
Pharma
2,305.55 78,030.29 11.37 71.07 32.44 16.43 18.10 10.14 30.05
Peer Comparison
https://www.topstockresearch.com/rt/Stock/
MANKIND/FundamentalAnalysis

7. FINANCIAL RESOURCES OF COMPETITORS
Field TTM YoY
Growth
QoQ
Growth
Revenue 46304.89
(Cr)
13.53 % 2.11 %
Gross
Profit
35500.64
(Cr)
60.38 % 2.42 %
EBITDA 12797.78
(Cr)
79.34 % 6.98 %
Net
Profit
8548.53
(Cr)
161.58 % 17.45 %
EPS 35.63 159.56 % NA
Growth Key Fields
SUNPHARMA DRREDDY
Field TTM YoY Growth QoQ
Growt
h
Revenue 26765.50
(Cr)
14.50 % 2.14 %
Gross Profit 18108.00
(Cr)
78.30 % 1.65 %
EBITDA 8251.10 (Cr) 75.01 % 3.89 %
Net Profit 5091.20 (Cr) 106.52 % 5.49 %
EPS 305.86 106.33 % NA
Growth Key Fields
https://www.topstockresearch.com/

8. Field TTM YoY
Growth
QoQ
Growth
Revenue 24556.43
(Cr)
4.55 % 5.52 %
Gross
Profit
15805.98
(Cr)
8.33 % 8.25 %
EBITDA 6157.86
(Cr)
14.37 % 15.70 %
Net Profit 3453.22
(Cr)
10.78 % 13.58 %
EPS 42.78 11.28 % NA
CIPLA
Field TTM YoY
Growth
QoQ
Growth
Revenue 10233.00
(Cr)
13.07 % 2.66 %
Gross
Profit
7343.00
(Cr)
10.95 % 3.69 %
EBITDA 2953.00
(Cr)
34.72 % 17.82 %
Net Profit 1334.00
(Cr)
60.19 % 2.12 %
EPS 39.41 60.16 % NA
TORNT PHARM
Field TTM YoY Growth QoQ Growth
Revenue 9430.32 (Cr) 12.44 % 5.02 %
Gross Profit 1758.66 (Cr) 100.00 % 100.00 %
EBITDA 2370.48 (Cr) 7.64 % 3.53 %
Net Profit 1557.49 (Cr) 10.58 % 2.91 %
EPS 38.87 10.56 % NA
MANKIND

10. Rank Company Market Share (December 2023)
1 Sun Pharma ₹295,466 crore (US$37 billion)
2 Cipla ₹100,787 crore (US$13 billion)
3
Dr. Reddy's
Laboratories
₹98,218 crore (US$12 billion)
4
Divi's
Laboratories
₹96,242 crore (US$12 billion)
5
Mankind
Pharma
₹76,792 crore (US$9.6 billion)
6
Torrent
Pharmaceuticals
₹72,168 crore (US$9.0 billion)
7
Zydus
Lifesciences
₹64,305 crore (US$8.1 billion)
8
Aurobindo
Pharma
₹61,154 crore (US$7.7 billion)
9 Lupin ₹57,530 crore (US$7.2 billion)
10
Alkem
Laboratories
₹55,064 crore (US$6.9 billion
MARKET SHARES OF COMPETITORS
www. Marketstocks.com

11. MARKETING STRATEGY OF
COMPETITORS
www.pharmamarketing.com

12. STRENGTH OF COMPETITORS
•Pharmaceutical companies that operate on Blockbuster business
model
• Research & Development with the companies rather than
outsourcing, Development and production or manufacturing of
various drugs/ medicines and healthcare products.
•Testing of drugs, marketing and distribution of drugs to
appropriate customer segments using various marketing and
distribution channels, and managing internal personnel, production,
costing, etc

13. WEEKNESS OF COMPETITORS

14. Thank you